Clinical events and healthcare resource utilization associated with neutropenia and leukopenia among adult kidney transplant recipients receiving valganciclovir
Adults receiving valganciclovir and/or ganciclovir prophylaxis post-kidney transplantation had greater risk of neutropenia and/or leukopenia, which were associated with higher clinical event rates and HCRU up to 5 years post-transplantation. These findings suggest the need for alternative prophylaxis options with lower myelosuppressive effects to improve patient outcomes.
Authors
- Pamela Moise
- Flavio Vincenti (ORCID: https://orcid.org/0000-0002-6701-4680)
- Cheryl Xiang
- Martha Pavlakis (ORCID: https://orcid.org/0000-0003-1032-0801)
- Weijia Wang (ORCID: https://orcid.org/0000-0002-7707-5022)
- Michael Wong (ORCID: https://orcid.org/0000-0002-3459-501X)
- Wei Gao (ORCID: https://orcid.org/0000-0001-9261-3127)
- Pangsibo Shen
- A Beyer
Institutions
- Analysis Group (United States) (US)
Publication Details
- Journal
- World Journal of Transplantation
- Published
- 2025-02-21
- DOI
- https://doi.org/10.5500/wjt.v15.i2.102671
- Citations
- 1
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 1.35